Presentation Information

[ES-11-1]How to properly proceed with anti-amyloid-β antibody therapy for early-stage Alzheimer's disease

Ryoko Ihara (Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)